StockNews.com assumed coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Free Report) in a report issued on Thursday morning. The firm issued a sell rating on the stock.
Separately, Craig Hallum upgraded Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.
Read Our Latest Stock Report on Streamline Health Solutions
Streamline Health Solutions Stock Performance
Streamline Health Solutions (NASDAQ:STRM – Get Free Report) last released its quarterly earnings results on Wednesday, September 11th. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.01). Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%. The firm had revenue of $4.48 million for the quarter.
About Streamline Health Solutions
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
Read More
- Five stocks we like better than Streamline Health Solutions
- What Are Some of the Best Large-Cap Stocks to Buy?
- Is Spotify Stock Poised to Soar? Options Traders Think So
- Dividend Payout Ratio Calculator
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Short Selling: How to Short a Stock
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.